Discovery of novel Bcr–Abl inhibitors targeting myristoyl pocket and ATP site

Bioorganic & Medicinal Chemistry
2014.0

Abstract

Bcr-Abl plays an essential role in the pathogenesis and development of chronic myeloid leukaemia (CML). Inhibition of Bcr-Abl has great potential for therapeutic intervention in CML. In order to obtain novel and potent Bcr-Abl inhibitors, twenty seven 4,6-disubstituted pyrimidines were synthesized and evaluated herein. The biological results indicated that four compounds of them (C4, C5, C16, and C23) were potent Bcr-Abl inhibitors which were comparable to positive control. Moreover, C4 and C5 displayed promising antiproliferative activity against K562 cells. The results suggested that these 4,6-disubstituted pyrimidines could serve as promising leads for further optimization of Bcr-Abl inhibitors.

DOI： 10.1016/j.bmc.2014.10.030

Knowledge Graph

Similar Paper

Discovery of novel Bcr–Abl inhibitors targeting myristoyl pocket and ATP site
Bioorganic & Medicinal Chemistry 2014.0
Synthesis and biological evaluation of novel aromatic amide derivatives as potential BCR-ABL inhibitors
Bioorganic & Medicinal Chemistry Letters 2023.0
Hybrid compounds as new Bcr/Abl inhibitors
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents
European Journal of Medicinal Chemistry 2015.0
Potent and selective inhibitors of the Abl-kinase: phenylamino-pyrimidine (PAP) derivatives
Bioorganic & Medicinal Chemistry Letters 1997.0
Hybrid pyrimidine alkynyls inhibit the clinically resistance related Bcr-AblT315I mutant
Bioorganic & Medicinal Chemistry Letters 2015.0
Design, synthesis, and biological activity of 4-(imidazo[1,2- b ]pyridazin-3-yl)-1 H -pyrazol-1-yl-phenylbenzamide derivatives as BCR–ABL kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2016.0
Expanding the structural diversity of Bcr-Abl inhibitors: Hybrid molecules based on GNF-2 and Imatinib
Bioorganic & Medicinal Chemistry Letters 2015.0
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines
European Journal of Medicinal Chemistry 2008.0
Design, synthesis and evaluation of (E)-α-benzylthio chalcones as novel inhibitors of BCR-ABL kinase
Bioorganic & Medicinal Chemistry 2010.0